Cargando…
Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence
BACKGROUND: The behavioural impact of pharmacogenomics is untested; informing smokers of genetic test results for responsiveness to smoking cessation medication may increase adherence to this medication. The objective of this trial is to estimate the impact upon adherence to nicotine replacement the...
Autores principales: | Marteau, Theresa M, Munafò, Marcus R, Aveyard, Paul, Hill, Chloe, Whitwell, Sophia, Willis, Thomas A, Crockett, Rachel A, Hollands, Gareth J, Johnstone, Elaine C, Wright, Alison J, Prevost, A Toby, Armstrong, David, Sutton, Stephen, Kinmonth, Ann Louise |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996370/ https://www.ncbi.nlm.nih.gov/pubmed/21062464 http://dx.doi.org/10.1186/1471-2458-10-680 |
Ejemplares similares
-
Effect on Adherence to Nicotine Replacement Therapy of Informing Smokers Their Dose Is Determined by Their Genotype: A Randomised Controlled Trial
por: Marteau, Theresa M., et al.
Publicado: (2012) -
Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking
por: Whitwell, Sophia CL, et al.
Publicado: (2011) -
Effect of communicating DNA based risk assessments for Crohn’s disease on smoking cessation: randomised controlled trial
por: Hollands, Gareth J, et al.
Publicado: (2012) -
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): trial protocol
por: Mann, Eleanor, et al.
Publicado: (2009) -
Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial
por: Marteau, Theresa M, et al.
Publicado: (2010)